Advisor Group Holdings, Inc. Alvotech Transaction History
Advisor Group Holdings, Inc.
- $67.1 Billion
- Q3 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Alvotech stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,033 shares of ALVO stock, worth $5,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,033
Previous 327
215.9%
Holding current value
$5,671
Previous $2,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ALVO
# of Institutions
65Shares Held
15MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.35MShares$23.9 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$14.9 Million12.58% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.56MShares$8.58 Million0.33% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.45MShares$7.98 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$7.24 Million12.0% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $1.37B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...